Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin

Cornea

Volumn 19, Issue 2, 2000, Pages 212-217

  Shin, Seung Hwan ^a   Kim, Jae Chan ^a,d   Chang, Soo Ik ^b   Lee, Hyosil ^c   Chung, Soo Il ^c  

^a Chung Ang University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Mogam Biotechnology Research Institute   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Angiogenesis; Angiogenin; Corneal micropocket assay; Recombinant kringle 1 3 of plasminogen

Indexed keywords

ANGIOGENIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CORNEA CELL; DRUG EFFECT; ENDOTHELIUM CELL; IMPLANTATION; KRINGLE DOMAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT; RECEPTOR DOWN REGULATION; TARGET CELL; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; LEUKOCYTES; MALE; PEPTIDE FRAGMENTS; PLASMINOGEN; RABBITS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; RIBONUCLEASE, PANCREATIC;

EID: 0037931645     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200003000-00016     Document Type: Article

References (30)

1. Epstein RJ, Stulting RD, Hendrick RL, Harris DM. Corneal neovascularization: pathogenesis and inhibition. Cornea 1987;6:250-8.
2. Hill JC, Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 1988;46:26-30.
3. Bouck N. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 1990;2:179-85.
4. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-4.
5. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical application of research on angiogenesis. N EnglJ Med 1995;333:1757-63.
6. Good DJ, Polverini PJ, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990;87:6624-8.
7. Van Meir EG, Polverini PJ, Chazin VR, Su Huang HJ, de Tribolet N, Cavenee WK. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 1994;8:171-6.
8. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
9. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumor in mice. Nat Med 1996;2:689-92.
10. Cao Y, Ji RW, Davidson D, et al. Kringle domain of human angiostatin, characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996;271:29461-7.
11. Adamis AP, Meklir B, Joyce NC. In situ injury-induced release of basic-fibroblast growth factor from corneal endothelial cells. Am J Pathol 1991;139:961-6.
12. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998;39:18-22.
13. 1 and copper in angiogenesis. J Natl Cancer Inst 1982;69:475-80.
14. Lipman RM, Epstein RJ, Hendricks RL. Suppression of corneal neovascularization with cyclosporin. Arch Ophthalmol 1992;110: 405-7.
15. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
16. Risau W. Angiogenic growth factors. Prog Growth Factor Res 1990;2:71-9.
17. Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480-6.
18. Bond MD, Vallee BL. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay. Biochemistry 1988;27:6282-7.
19. Chang SI, Paik SB, So SH, Ahn BC. Interaction between a blood vessel-inducing protein angiogenin and its binding protein actin. J Biochem Mol Biol 1996;29:353-8.
20. Loughnan MS, Chatzistefanou K, Gonzalez EM, et al. Experimental corneal neovascularisation using sucralfate and basic fibroblast factor. Aust N Z J Ophthalmol 1996;24:289-95.
21. Hu GF. Limited proteolysis of angiogenin by elastase is regulated by plasminogen. J Protein Chem 1997;16:669-79.
22. Schott RJ, Marrow LA. Growth factors and angiogenesis. Cardiovasc Res 1993;27:1155-61.
23. King TV, Vallee BL. Neovascularisation of the meniscus with angiogenin: an experimental study in rabbits. J Bone Joint Surg Br 1991;73:587-90.
24. Badet J, Soncin F, Guitton JD, Lamare O, Cartwright T, Barritault D. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell. Proc Natl Acad Sci U S A 1989;86:8427-31.
25. Hu G, Riordan JF, Valle BL. Angigenin promotes invasiveness of cultured endothelial cells by stimulation of cell. Proc Natl Acad Sci U S A 1994;91:12096-100.
26. Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion associated proteolytic activities. Proc Natl Acad Sci U S A 1992;89:2232-6.
27. Jim SI, Ito KI, Kohno K, et al. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem Biophys Res Commun 1995;211:476-83.
28. Chen C, Parangi S, Tolentino M, Folkman J. A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 1995;55:4230-3.
29. O'Reilly MS, Boehm T, Shin Y, et al. Endostatin: an endogenous inhibition of angiogenesis and tumor growth. Cell 1997;88:1-20.
30. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997;88:801-10.